1. Home
  2. MRVI vs PKST Comparison

MRVI vs PKST Comparison

Compare MRVI & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • PKST
  • Stock Information
  • Founded
  • MRVI 2014
  • PKST 2008
  • Country
  • MRVI United States
  • PKST United States
  • Employees
  • MRVI N/A
  • PKST N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • PKST Real Estate Investment Trusts
  • Sector
  • MRVI Health Care
  • PKST Real Estate
  • Exchange
  • MRVI Nasdaq
  • PKST Nasdaq
  • Market Cap
  • MRVI 449.6M
  • PKST 514.0M
  • IPO Year
  • MRVI 2020
  • PKST N/A
  • Fundamental
  • Price
  • MRVI $3.69
  • PKST $13.58
  • Analyst Decision
  • MRVI Buy
  • PKST Strong Buy
  • Analyst Count
  • MRVI 7
  • PKST 2
  • Target Price
  • MRVI $4.54
  • PKST $17.50
  • AVG Volume (30 Days)
  • MRVI 1.6M
  • PKST 193.5K
  • Earning Date
  • MRVI 11-06-2025
  • PKST 11-05-2025
  • Dividend Yield
  • MRVI N/A
  • PKST 2.96%
  • EPS Growth
  • MRVI N/A
  • PKST N/A
  • EPS
  • MRVI N/A
  • PKST N/A
  • Revenue
  • MRVI $192,435,000.00
  • PKST $221,496,000.00
  • Revenue This Year
  • MRVI N/A
  • PKST N/A
  • Revenue Next Year
  • MRVI $7.27
  • PKST N/A
  • P/E Ratio
  • MRVI N/A
  • PKST N/A
  • Revenue Growth
  • MRVI N/A
  • PKST 48.03
  • 52 Week Low
  • MRVI $1.67
  • PKST $10.14
  • 52 Week High
  • MRVI $6.21
  • PKST $15.40
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 61.86
  • PKST 50.60
  • Support Level
  • MRVI $3.37
  • PKST $13.00
  • Resistance Level
  • MRVI $3.76
  • PKST $14.19
  • Average True Range (ATR)
  • MRVI 0.25
  • PKST 0.68
  • MACD
  • MRVI 0.05
  • PKST -0.10
  • Stochastic Oscillator
  • MRVI 94.02
  • PKST 38.99

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

Share on Social Networks: